#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Polymyositis Activated PI3 kinase delta syndrome Scleroderma associated digital ulcer Metastatic malignant melanoma Progressive familial intrahepatic cholestasis Hypophosphatasia Haemolytic uraemic syndrome Transitional cell cancer of the renal pelvis and ureter Anti-glomerular basement membrane disease Non-small cell lung cancer recurrent Infantile spasms Univentricular heart Autoimmune disorder Congenital pseudarthrosis Thromboangiitis obliterans More trials…

    Learn about Rare Diseases

    Pemphigus – Life with Disease Von Willebrand’s disease – Treatment Rosai-Dorfman syndrome – Trials in Disease Alternating hemiplegia of childhood Choroid melanoma – Life with Disease Myxofibrosarcoma – Diagnostics Hypereosinophilic syndrome – Trials in Disease Leiomyosarcoma metastatic – Treatment Acute respiratory distress syndrome – Basic Information Hyperoxaluria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sertindole Anhydrous Glucose Bp Oxitriptan Azetukalner Iptacopan Hydrochloride Rct2100 Dazodalibep Ganciclovir Orlistat Aluminium Acoramidis Divarasib Interferon Beta-1A Calcium Oxybate S095035 Transpocart19 Milvexian 19Cp02 Bepranemab [18F]CPFPX More therapies…

    Learn about Your Condition

    Chronic lymphocytic leukaemia Metastasis Small fibre neuropathy Penile squamous cell carcinoma Senile dementia Ovarian epithelial cancer Breast neoplasm Peripheral artery restenosis Alpha-1 antitrypsin deficiency Post-traumatic stress disorder Cardiac valve disease H1N1 influenza Electrocorticogram Haemorrhage Mixed dementia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of rituximab and glucocorticoids versus placebo and glucocorticoids in adults with newly diagnosed or relapsing IgA vasculitis

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Henoch-Schonlein purpura
    Investigated Drugs:
    • Rituximab
    France

  • Study of L19TNF and Lomustine for Patients with Recurrent or Progressive Glioblastoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Lomustine
    • Onfekafusp Alfa
    Germany Italy

  • Study of Niraparib and Dostarlimab for Patients with Advanced Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma with Specific Genetic Mutations

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma
    • Non-small cell lung cancer
    Investigated Drugs:
    • Dostarlimab
    • Niraparib
    Italy

  • Study on the Long-Term Effects of Gadoxetic Acid, Gadoteridol, and Gadobenate Dimeglumine on Motor and Cognitive Functions in Healthy Adults

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    Investigated Drugs:
    • Gadobenate Dimeglumine
    • Gadoteridol
    • Gadoxetic Acid, Disodium
    France Germany Italy

  • Study on the Safety of Dasatinib and Quercetin for Patients with Mild Cognitive Impairment or Early Alzheimer’s Disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Quercetin
    • Dasatinib
    Spain

  • Study on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • His203-Crm197
    • Paracetamol
    Czechia Denmark France Poland Romania
Previous Page
1 … 830 831 832 833 834 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!